International Journal of Oncology

EXPRESSION OF ETS FAMILY GENES IN HEMATOPOIETIC-CELLS
pp. 521-531(11)
Authors: ROMANOSPICA, V; SUZUKI, H; GEORGIOU, P; CHEN, SL; ASCIONE, R; PAPAS, TS; BHAT, NK

INTERACTION OF BLOOM-SYNDROME CELLULAR CANCER ANTIGENS WITH SERA OF MALIGNANT-LYMPHOMA PATIENTS - AN IMMUNOLOGICAL AND CYTOGENETICAL STUDY
pp. 533-541(9)
Author: SHIRAISHI, Y

ALLELE LOSS ON CHROMOSOME-3 IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK CORRELATES WITH POOR CLINICAL PROGNOSTIC INDICATORS
pp. 543-549(7)
Authors: FIELD, JK; TSIRIYOTIS, C; ZOUMPOURLIS, V; HOWARD, P; SPANDIDOS, DA; JONES, AS

GELATINASE-A/MMP-2 SERUM LEVELS AND NEOPLASTIC PROGRESSION IN BREAST-CANCER PATIENTS
pp. 551-554(4)
Authors: LEONE, A; CORREALE, M; DRAGONE, CD; PARADISO, A; DELENA, M; STETLERSTEVENSON, WG; LIOTTA, LA; MASIERO, L; GARBISA, S

INTERLEUKIN-1 RECEPTOR ANTAGONIST INHIBITS GROWTH MODULATION OF HUMAN TUMOR-CELL LINES BY INTERLEUKIN-1 IN-VITRO
pp. 555-558(4)
Authors: OELMANN, E; TOPP, MS; REUFI, B; PAPADIMITRIOU, C; KOENIGSMANN, M; OBERBERG, D; THIEL, E; BERDEL, WE

ORAL VERSUS INTRAVENOUS CMF IN METASTATIC BREAST-CANCER - A RANDOMIZED STUDY
pp. 559-565(7)
Authors: BRANDI, M; DEMITRIO, A; DITONNO, P; CATINO, A; LORUSSO, V; DELENA, M

PROGNOSTIC-SIGNIFICANCE OF P53 MUTATIONS IN SMALL NON-CLEAVED CELL LYMPHOMAS
pp. 567-571(5)
Authors: GUTIERREZ, MI; BHATIA, K; DIEZ, B; MURIEL, FS; EPELMAN, S; DEANDREAS, ML; HUPPI, K; MAGRATH, I

MUTATIONAL ACTIVATION OF K-RAS ONCOGENE IN HUMAN BREAST-TUMORS
pp. 573-576(4)
Authors: KOFFA, M; MALAMOUMITSI, V; AGNANTIS, NJ; SPANDIDOS, DA

HYPERFRACTIONATED SPLIT-COURSE THORACIC RADIATION-THERAPY PLUS CHEMOTHERAPY IN LOCALLY ADVANCED NONSMALL CELL LUNG-CANCER
pp. 577-582(6)
Authors: IAFFAIOLI, RV; TORTORIELLO, A; FACCHINI, G; CAPONIGRO, F; FRASCI, G; PANELLI, G; RAVO, V; MUTO, P

ESTABLISHMENT OF 2 HUMAN THYROID-CARCINOMA CELL-LINES (8305C, 8505C) BEARING P53 GENE-MUTATIONS
pp. 583-586(4)
Authors: ITO, T; SEYAMA, T; HAYASHI, Y; HAYASHI, T; DOHI, K; MIZUNO, T; IWAMOTO, KS; TSUYAMA, N; NAKAMURA, N; AKIYAMA, M

PAPILLARY CYSTADENOCARCINOMA OF SALIVARY-GLANDS - AN IMMUNOHISTOCHEMICAL STUDY
pp. 587-597(11)
Authors: SHRESTHA, P; NAMBA, M; YANG, LJ; LIU, BL; OOSUMI, H; MORI, M

MECHANISMS OF DEREGULATED HER2/NEU EXPRESSION IN BREAST-CANCER CELL-LINES
pp. 599-608(10)
Authors: MILLER, SJ; SUEN, TC; SEXTON, TB; HUNG, MC

FRAMESHIFT AND NONSENSE P53 MUTATIONS IN SQUAMOUS-CELL CARCINOMA OF HEAD AND NECK - NON-REACTIVITY WITH 3 ANTI-P53 MONOCLONAL-ANTIBODIES
pp. 609-614(6)
Authors: CHEN, YT; XU, L; MASSEY, L; ZLOTOLOW, IM; HUVOS, AG; GARINCHESA, P; OLD, LJ

MOLECULAR ASPECTS OF HEPATOCARCINOGENESIS AND THEIR CLINICAL IMPLICATIONS - REVIEW
pp. 615-622(8)
Authors: NISHIDA, N; FUKUDA, Y; ISHIZAKI, K

THE RET PROTOONCOGENE IS EXPRESSED IN NORMAL HUMAN PARAFOLLICULAR THYROID-CELLS
pp. 623-626(4)
Authors: FABIEN, N; PAULIN, C; SANTORO, M; BERGER, N; GRIECO, M; DUBOIS, PM; FUSCO, A

RAS P21 OVEREXPRESSION IS A LATE EVENT IN PROSTATE-CANCER
pp. 627-631(5)
Authors: HAMDY, SM; APRIKIAN, AG; BEGIN, LR; FAIR, WR; BAZINET, M

CONSTITUTIVE EXPRESSION OF IMMUNOSUPPRESSION-ASSOCIATED CYTOKINE GENES IN A PANEL OF HUMAN T-LEUKEMIA-CELL LINES - HIGH-INCIDENCE OF TRANSFORMING GROWTH-FACTOR-BETA GENE-EXPRESSION
pp. 633-638(6)
Authors: MICALLEF, M; ARIYASU, T; DAO, T; MATSUO, Y; MINOWADA, J

A MULTIATTRIBUTE APPROACH TO HEALTH-STATUS MEASUREMENT AND CLINICAL MANAGEMENT ILLUSTRATED BY AN APPLICATION TO BRAIN-TUMORS IN CHILDHOOD
pp. 639-648(10)
Authors: BARR, RD; PAI, MKR; WEITZMAN, S; FEENY, D; FURLONG, W; ROSENBAUM, P; TORRANCE, GW

BCL-2 GENE PREVENTS INDUCTION OF APOPTOSIS IN L1210 MURINE LEUKEMIA-CELLS BY SN-38, A METABOLITE OF THE CAMPTOTHECIN DERIVATIVE CPT-11
pp. 649-654(6)
Authors: KONDO, S; YIN, D; MORIMURA, T; TAKEUCHI, J

DOXORUBICIN ENHANCES TRANSIENT EXPRESSION OF P-GLYCOPROTEIN AND MODULATES ACTIVITY AND ISOFORM EXPRESSION OF PROTEIN-KINASE-C IN AH66 RAT HEPATOMA-CELLS
pp. 655-659(5)
Authors: OHKAWA, K; HATANO, T; ISONISHI, S; TAKADA, K; JOH, K; MATSUDA, M

CHEMOPREVENTION OF RESPIRATORY-TRACT NEOPLASIA IN THE HAMSTER BY OLTIPRAZ, ALONE AND IN COMBINATION
pp. 661-667(7)
Authors: MOON, RC; RAO, KVN; DETRISAC, CJ; KELLOFF, GJ; STEELE, VE; DOODY, LA

TYPE-I AND TYPE-III PROCOLLAGEN METABOLITES AND CA 125 IN EPITHELIAL OVARIAN-CANCER
pp. 669-674(6)
Authors: ZHU, GG; PUISTOLA, U; RISTELI, J; RISTELI, L; KAUPPILA, A

PREDICTION OF PROGNOSIS AFTER RESECTION IN HUMAN HEPATOMAS BY NUCLEAR-DNA ANALYSIS
pp. 675-679(5)
Authors: UNE, Y; UCHINO, J; MISAWA, K; KAMIYAMA, T; ISHIZU, H; SATO, N; NAKAJIMA, Y; HATA, Y

TOXICITY IN LONG-TERM SURVIVORS AFTER ADRIAMYCIN CONTAINING CHEMOTHERAPY OF MALIGNANT GERM-CELL TUMORS
pp. 681-688(8)
Authors: WANDERAS, EH; FOSSA, SD; TRETLI, S; KLEPP, O

AIDS-ASSOCIATED KAPOSIS-SARCOMA IN TANZANIANS OF INDIAN ORIGIN - REPORT OF CASES AND REVIEW OF LITERATURE
pp. 689-693(5)
Authors: KAAYA, EE; AMIR, H; KITINYA, J; LUANDE, J; ORDONEZ, C; BIBERFELD, P

FACTORS MODIFYING THE RISK OF ACUTE AND CONDITIONED NAUSEA AND VOMITING IN OVARIAN-CANCER PATIENTS
pp. 695-701(7)
Authors: HURSTI, TJ; FREDRIKSON, M; FURST, CJ; BORJESON, S; PETERSON, C; STEINECK, G

A COMPARISON OF THE HEALTH-PROMOTING LIFE-STYLE PROFILE OF OVARIAN-CANCER PATIENTS AND HEALTHY WOMEN
pp. 703-707(5)
Authors: LOESCH, M; FISCHER, M; SHURPIN, KM; MANN, WJ

IN-VITRO SCHEDULE-DEPENDENCY OF EO9 AND MILTEFOSINE IN COMPARISON TO STANDARD DRUGS IN COLON-CANCER CELLS
pp. 709-715(7)
Authors: VANARKOTTE, J; PETERS, GJ; PIZAO, PE; KEEPERS, YPAM; GIACCONE, G

PROTEASES ASSOCIATED WITH GYNECOLOGICAL TUMORS
pp. 717-721(5)
Authors: RUPPERT, C; EHRENFORTH, S; TUTSCHEK, B; VERING, A; BECKMANN, MW; SCHARRER, I; BENDER, HG